Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Nick David Bergkamp

Title(s)Postdoctoral Scholar, Pharmacology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
ORCID ORCID Icon0000-0001-5692-5975 Additional info
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms. Proc Natl Acad Sci U S A. 2025 Jun 17; 122(24):e2424186122. Mobach S, Bergkamp ND, Ma Z, Haselager MV, Anbuhl SM, Jurriens D, van den Bor J, Wang Z, Crudden C, Roos JL, Perez Almeria CV, Boergonje RA, Lohse MJ, Bosma R, Eldering E, Siderius M, Wu W, Spaargaren M, Tonino SH, Kater AP, Smit MJ, Heukers R. PMID: 40498456; PMCID: PMC12184429.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Presentation of CXCL12? by heparan sulfate proteoglycans activates CXCR4 without desensitization in normal and malignant B cells. Blood Adv. 2025 May 13; 9(9):2307-2320. Lantermans HC, Ma F, Kuil A, de Rooij MFM, Bergkamp ND, van der Meer W, van Buul JD, Smit MJ, Kersten MJ, Spaargaren M, Pals ST. PMID: 39969206; PMCID: PMC12127637.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Pharmacological characterization of a clinical candidate, TG-0054, a small molecule inverse agonist targeting CXCR4. Mol Pharmacol. 2025 Apr; 107(4):100015. Pan KS, Wang Z, Pfeil C, Bergkamp ND, Mobach S, Roth S, Rizk A, Lohse MJ, Annibale P, Siderius M, Zimmermann M, Smit MJ, Bosma R. PMID: 40156952.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    4. Learning from serum markers reflecting endothelial activation: longitudinal data in childhood-onset systemic lupus erythematosus. Lupus Sci Med. 2024 Sep 05; 11(2). Bergkamp SC, Bergkamp ND, Wahadat MJ, Gruppen MP, Nassar-Sheikh Rashid A, Tas SW, Smit MJ, Versnel MA, van den Berg JM, Kamphuis S, Schonenberg-Meinema D. PMID: 39242108; PMCID: PMC11381702.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    5. A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P1 signaling axis. Sci Signal. 2023 Aug 15; 16(798):eade6737. Bergkamp ND, van Senten JR, Brink HJ, Bebelman MP, van den Bor J, Çobanoglu TS, Dinkla K, Köster J, Klau G, Siderius M, Smit MJ. PMID: 37582160.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    6. Exosomal release of the virus-encoded chemokine receptor US28 contributes to chemokine scavenging. iScience. 2023 Aug 18; 26(8):107412. Bebelman MP, Setiawan IM, Bergkamp ND, van Senten JR, Crudden C, Bebelman JPM, Verweij FJ, van Niel G, Siderius M, Pegtel DM, Smit MJ. PMID: 37575190; PMCID: PMC10415803.
      View in: PubMed   Mentions: 3  
    7. Monitoring Snake Venom-Induced Extracellular Matrix Degradation and Identifying Proteolytically Active Venom Toxins Using Fluorescently Labeled Substrates. Biology (Basel). 2023 May 24; 12(6). Bittenbinder MA, Bergkamp ND, Slagboom J, Bebelman JPM, Casewell NR, Siderius MH, Smit MJ, Kool J, Vonk FJ. PMID: 37372050; PMCID: PMC10295075.
      View in: PubMed   Mentions:
    8. NanoB2 to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRET. Cell Rep Methods. 2023 Mar 27; 3(3):100422. van den Bor J, Bergkamp ND, Anbuhl SM, Dekker F, Comez D, Perez Almeria CV, Bosma R, White CW, Kilpatrick LE, Hill SJ, Siderius M, Smit MJ, Heukers R, van den Bor J, Bergkamp ND, Anbuhl SM, Dekker F, Comez D, Perez Almeria CV, Bosma R, White CW, Kilpatrick LE, Hill SJ, Siderius M, Smit MJ, Heukers R. PMID: 37056381; PMCID: PMC10088090.
      View in: PubMed   Mentions: 6     Fields:    
    9. Computationally designed GPCR quaternary structures bias signaling pathway activation. Nat Commun. 2022 Nov 11; 13(1):6826. Paradis JS, Feng X, Murat B, Jefferson RE, Sokrat B, Szpakowska M, Hogue M, Bergkamp ND, Heydenreich FM, Smit MJ, Chevigné A, Bouvier M, Barth P. PMID: 36369272; PMCID: PMC9652377.
      View in: PubMed   Mentions: 12     Fields:    Translation:Cells
    10. Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies. Nat Commun. 2021 Jul 21; 12(1):4436. De Groof TWM, Elder EG, Lim EY, Heukers R, Bergkamp ND, Groves IJ, Wills M, Sinclair JH, Smit MJ. PMID: 34290252; PMCID: PMC8295288.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    11. Selective targeting of ligand-dependent and -independent signaling by GPCR conformation-specific anti-US28 intrabodies. Nat Commun. 2021 Jul 16; 12(1):4357. De Groof TWM, Bergkamp ND, Heukers R, Giap T, Bebelman MP, Goeij-de Haas R, Piersma SR, Jimenez CR, Garcia KC, Ploegh HL, Siderius M, Smit MJ. PMID: 34272386; PMCID: PMC8285524.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    12. Human Cytomegalovirus-Encoded G Protein-Coupled Receptor UL33 Facilitates Virus Dissemination via the Extracellular and Cell-to-Cell Route. Viruses. 2020 May 30; 12(6). van Senten JR, Bebelman MP, van Gasselt P, Bergkamp ND, van den Bor J, Siderius M, Smit MJ. PMID: 32486172; PMCID: PMC7354556.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    13. The human cytomegalovirus-encoded G protein-coupled receptor UL33 exhibits oncomodulatory properties. J Biol Chem. 2019 Nov 01; 294(44):16297-16308. van Senten JR, Bebelman MP, Fan TS, Heukers R, Bergkamp ND, van Gasselt P, Langemeijer EV, Slinger E, Lagerweij T, Rahbar A, Stigter-van Walsum M, Maussang D, Leurs R, Musters RJP, van Dongen GAMS, Söderberg-Nauclér C, Würdinger T, Siderius M, Smit MJ. PMID: 31519750; PMCID: PMC6827316.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    14. Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells. Mol Pharm. 2019 Jul 01; 16(7):3145-3156. De Groof TWM, Mashayekhi V, Fan TS, Bergkamp ND, Sastre Toraño J, van Senten JR, Heukers R, Smit MJ, Oliveira S. PMID: 31244224; PMCID: PMC6728091.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    Nick David's Networks
    Concepts (84)
    Derived automatically from this person's publications.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-16-gff1bd585 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California